Abstract 2718 My career-long fascination with antiviral therapeutics

I entered graduate school at the beginning of the race for development of therapeutics to treat HIV.Since that time, I have contributed in one small way or another to the discovery of targets, off-targets, and/or mechanisms for antivirals developed over the past 30 years or so.In my talk, I will share some of the highlights of my career, lessons learned, and pay homage to the many, many mentors and collaborators that I have encountered along the way.I will also share some of the most recent data from the laboratory that reveal the impact of analyzing the efficacy of antivirals on viral infection dynamics one cell at a time.